Ranbaxy Laboratories is currently trading at Rs. 341.50, up by 1.45 points or 0.43 % from its previous closing of Rs. 340.05 on the BSE.
The scrip opened at Rs. 342.70 and has touched a high and low of Rs. 344.25 and Rs. 338.00 respectively. So far 170923 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 490.15 on 06-Jan-2014 and a 52 week low of Rs. 253.95 on 02-Aug-2013.
Last one week high and low of the scrip stood at Rs. 347.00 and Rs. 308.00 respectively. The current market cap of the company is Rs. 14410.61 crore.
The promoters holding in the company stood at 63.41 % while Institutions and Non-Institutions held 19.55 % and 15.38 % respectively.
Ranbaxy Laboratories has reported results for fourth quarter ended December 31, 2013.
The company has reported a net loss at Rs 395.96 crore for the quarter as compared to net loss for Rs 616.09 crore for the same quarter in the previous year. Total income of the company decreased by 5.20% at Rs 1366.56 crore for quarter under review as compared to Rs 1441.52 crore for the quarter ended December 31, 2012.
For the year ended December 31, 2013, the company has posted net loss at Rs 1776.85 crore as compared to loss of Rs 162.33 crore in the previous year. Total income has decreased by 10.96% at Rs 5612.92 crore for year under review as compared to Rs 6303.54 crore for the period ended December 31, 2012.
On the consolidated basis, the group has reported a net loss after taxes and Minority Interest and Share of Profit of Associates of Rs 158.94 crore for the quarter as compared to net loss of Rs 492.44 crore for the same quarter in the previous year. However, total income from operations of the group has increased by 6.74% at Rs 2893.99 crore for quarter under review as compared to Rs 2711.21 crore for the quarter ended December 31, 2012.
For the year ended December 31, 2013, on the consolidated basis, a net loss after taxes and Minority Interest and Share of Profit of Associates of Rs 1011.59 crore as compared to net profit of Rs 922.76 crore for the same period in the previous year. Total income from operations has decreased by 13.31% at Rs 10801.66 crore for year under review as compared to Rs 12459.72 crore for the period ended December 31, 2012
The scrip opened at Rs. 342.70 and has touched a high and low of Rs. 344.25 and Rs. 338.00 respectively. So far 170923 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 490.15 on 06-Jan-2014 and a 52 week low of Rs. 253.95 on 02-Aug-2013.
Last one week high and low of the scrip stood at Rs. 347.00 and Rs. 308.00 respectively. The current market cap of the company is Rs. 14410.61 crore.
The promoters holding in the company stood at 63.41 % while Institutions and Non-Institutions held 19.55 % and 15.38 % respectively.
Ranbaxy Laboratories has reported results for fourth quarter ended December 31, 2013.
The company has reported a net loss at Rs 395.96 crore for the quarter as compared to net loss for Rs 616.09 crore for the same quarter in the previous year. Total income of the company decreased by 5.20% at Rs 1366.56 crore for quarter under review as compared to Rs 1441.52 crore for the quarter ended December 31, 2012.
For the year ended December 31, 2013, the company has posted net loss at Rs 1776.85 crore as compared to loss of Rs 162.33 crore in the previous year. Total income has decreased by 10.96% at Rs 5612.92 crore for year under review as compared to Rs 6303.54 crore for the period ended December 31, 2012.
On the consolidated basis, the group has reported a net loss after taxes and Minority Interest and Share of Profit of Associates of Rs 158.94 crore for the quarter as compared to net loss of Rs 492.44 crore for the same quarter in the previous year. However, total income from operations of the group has increased by 6.74% at Rs 2893.99 crore for quarter under review as compared to Rs 2711.21 crore for the quarter ended December 31, 2012.
For the year ended December 31, 2013, on the consolidated basis, a net loss after taxes and Minority Interest and Share of Profit of Associates of Rs 1011.59 crore as compared to net profit of Rs 922.76 crore for the same period in the previous year. Total income from operations has decreased by 13.31% at Rs 10801.66 crore for year under review as compared to Rs 12459.72 crore for the period ended December 31, 2012
No comments:
Post a Comment